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Abstract
The District of Columbia launched a routine HIV testing initiative in 2006. We examined HIV 
testing behaviors among heterosexuals at risk for HIV over time using CDC National HIV 
Behavioral Surveillance data from Washington, DC for the heterosexual cycles from 2006-7 
(“Cycle 1”) and 2010 (“Cycle 2”). Past year and past two-year HIV testing across study cycles 
were compared using chi-square tests. Weighted multivariable logistic regression identified 
correlates of past year testing. The majority of participants across both cycles were black and 
female. Cycle 1 participants were significantly more likely to have ≥4 partners in the past year, 
casual sex partners, and have anal sex at last sexual encounter (p<0.05). Lifetime testing was high, 
and individuals from Cycle 2 versus Cycle 1 were more likely to have been tested in the past two 
years. There were no significant differences in past year testing or being offered the HIV test at 
last health care visit by cycle. Independent correlates of past year testing were seeing a health care 
provider in the past year and using condoms at last vaginal sex. In conclusion, although past year 
testing did not differ between the two data collection years, the proportion of heterosexuals testing 
in the past two years was higher in Cycle 2 versus Cycle 1, suggesting successful expansion of 
HIV testing between the two time periods.
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 Introduction
Washington, DC has one of the highest HIV/AIDS case rates in the United States, with an 
estimated 2.7% of DC residents living with HIV (1). Heterosexual transmission accounted 
for nearly one-third of all newly diagnosed HIV cases in the District between 2006-10 
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(31.7%) (1), consistent with national level trends, in which heterosexual transmission 
accounted for 33% of new HIV cases reported in 2010 (2).
According to recent estimates, 21% of HIV infected individuals in the United States are 
unaware of their status (3). HIV testing is a major component of the National HIV/AIDS 
Strategy (NHAS) for the United States (4), yet according to recent National Health 
Information Survey data, only 45% of the general U.S. population has reported ever being 
tested for HIV (5). With the recent focus on the test and treat model, which supports the 
early identification of HIV-positive individuals and their immediate linkage to HIV care (6), 
and the launch of the NHAS (4), much importance has been placed on expanding HIV 
testing to identify new cases, particularly in high prevalence settings. Routine HIV testing 
has also been shown to be cost-effective (7).
In September 2006, the Centers for Disease Control and Prevention (CDC) released revised 
HIV testing guidelines recommending routine, opt-out HIV testing among all individuals 
between 13 and 64 years of age in jurisdictions with a HIV prevalence greater than 1% (8). 
In advance of these guidelines, the District of Columbia (DC), recognizing the severe impact 
the HIV epidemic has had on residents, launched a city-wide routine HIV testing initiative in 
June 2006 called “Come Together DC—Get Screened for HIV” (9, 10), in which the DC 
Department of Health coordinated an expansion of HIV testing through collaborations with 
community-based organizations, local emergency departments, and hospitals (10-12). 
Despite initial evaluations on the implementation of the routine HIV testing campaign (9, 
10), little research has been done to assess the potential ongoing, community-wide impact on 
HIV testing behaviors from the routine testing campaign in DC.
Using data from the CDC-funded National HIV Behavioral Surveillance (NHBS) system 
conducted in Washington, DC, this study sought to examine changes in HIV testing 
behaviors and assess correlates of past year testing among heterosexuals at elevated risk for 
HIV who participated in the 2006-7 and 2010 heterosexual NHBS cycles in the District of 
Columbia.
 Methods
 Study population and recruitment
NHBS has been conducted in Washington, DC by the District of Columbia Department of 
Health in partnership with the George Washington University School of Public Health and 
Health Services (GWU) since 2006. NHBS is comprised of serial, cross-sectional surveys of 
community-recruited individuals from the three highest risk groups for HIV acquisition: 
men who have sex with men (MSM), injection drug users (IDU), and heterosexuals at 
elevated risk for HIV (HET), which has been described extensively elsewhere (13-16). Data 
from the first NHBS data collection year (December 2006 to October 2007, or “Cycle 1”) 
and second data collection year (August to December 2010, or “Cycle 2”) for heterosexuals 
at elevated risk for HIV for Washington, DC were used for this analysis. Because the study 
design is cross-sectional and not longitudinal, separate groups of individuals were recruited 
during each data collection year.
Kuo et al. Page 2













Both study samples were recruited using respondent-driven sampling (RDS), which has been 
described elsewhere and has been used with heterosexual networks (13, 17-19). RDS is a 
chain-referral method that accesses hard-to-reach populations which can allow for 
generalizability to the population of networks from which the sample was drawn, given that 
certain assumptions are met [e.g., participants know one another as members of the 
population and come from dense networks to sustain long chains and recruitment waves 
form without too much insularity (homophily)] (13, 17-19). These assumptions were 
checked throughout the data collection process and at the end of the data collection periods 
to ensure that the assumptions were met. Individuals who were purposively-selected to start 
recruitment chains (also called “seeds”) completed a behavioral survey and a HIV test. All 
study interviews and procedures were conducted at the community-based GWU research 
clinic in Southeast DC in a professional office building. Seed and individuals who were 
eligible to recruit others for the study were asked to refer members of their social and sexual 
networks into the study. Individuals referred to the study who met the eligibility criteria also 
completed the survey, were offered an HIV test and were also assessed for eligibility to 
recruit members of their network. All study participants were compensated for completing 
the survey and taking the HIV test, and eligible recruiters were also compensated for each 
referral who was eligible and completed the study.
For the purposes of the NHBS study, the definition of “heterosexual” is self-reporting having 
had sex with a member of the opposite sex in the past 12 months, rather than being defined 
by self-reported sexual preference. For Cycle 1, eligibility included being male or female; 
aged 18-50; having had sex with a member of the opposite sex in the past year; and living in 
the DC metropolitan statistical area. For Cycle 2, the same inclusion criteria were used, 
except individuals aged 18-60 were eligible. There were also minor differences in the 
recruitment eligibility between the two study years. For the Cycle 1 sample, eligible 
recruiters had to live in protocol-designated high-risk areas, as determined by a complex 
algorithm that combined poverty (based on census data) and AIDS case rates (based on the 
AIDS case estimates available at the time of study conduct; HIV case data were not 
available at the time) (13). In 2010, participants who had a household income less than the 
U.S. Health and Human Services poverty guidelines and/or had a high school diploma or 
less were eligible to recruit. For this analysis, individuals who reported any injection drug 
use in the past year were excluded. In addition, the sample size goal (as determined by the 
CDC) was larger for Cycle 1 than Cycle 2 since Cycle 1 occurred over a period of two years 
(2006-7) versus one year for Cycle 2 (2010 only).
 Data collection
All data collection and study participation was anonymous. HIV screening was conducted 
using a rapid oral test (OraQuick Advance 1/2, OraSure Technologies, Bethlehem, PA). 
Confirmation of serostatus was conducted by Western Blot by whole blood for Cycle 1 and 
by oral specimen collected via OraSure test kit for Cycle 2.
Participants completed a computerized, interviewer-assisted, structured behavioral survey 
including questions on demographics, sexual/drug use behaviors, HIV testing behaviors 
(past year and past two years), and other potential correlates of HIV infection and testing, 
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such as seeing a medical provider in the past 12 months. The survey was developed, pre-
tested and pilot-tested extensively by the NHBS team at the CDC with input from staff from 
field sites. Although the same tool was used for both men and women, the computerized 
interviewed was programmed so that questions not relevant for a particular gender were not 
asked.
 Data analysis
 Univariate and bivariate analyses—To assess the effect of the launch of the 2006 
city-wide HIV testing program, the proportion of individuals testing in the past 12 months 
and past 24 months across Cycle 1 and Cycle 2 data collection years were compared. The 
proportion of those being offered a HIV test by a health care provider among those who 
sought care in the past 12 and 24 months were also compared across cycles, as well as HIV 
seroprevalence, testing behaviors and characteristics of the test itself. Demographic 
characteristics were analyzed for Cycle 1 and Cycle 2 separately due to differences in the 
recruitment criteria.
Because participants were recruited using RDS, all estimates were weighted using the RDS 
Analytical Tool (RDSAT v5.6.0) with enhanced data smoothing and 15,000 bootstraps. 
Since current IDUs were part of the recruitment chain in Cycle 1, trivalent weights were 
calculated (IDU-status by HIV testing by covariate). Individualized weights were exported 
from RDSAT v5.6.0 into SAS v9.2 (Cary, NC) for analysis. All weighted estimates were 
compared between the two data collection years using a chi-square test of proportions.
 Multivariate analyses—Because CDC testing guidelines recommend HIV screening 
among high risk populations on an annual basis (8), HIV testing in the past 12 months was 
used as the primary outcome for the multivariable analyses to examine the independent 
effect of data collection year and other demographic and behavioral correlates of HIV 
testing. With the exception of data collection year, which was retained in the model to assess 
its association with past year HIV testing and to adjust for overall differences in the two 
samples, backwards, manual step-wise elimination was used to build the multivariable 
model. Variables with a p-value ≤0.05 were retained in the final model. Although there is no 
consensus on weighting when building multivariable models using RDS data, following 
previous work using multivariable regression modeling with RDS-collected data (20, 21), 
data in the multivariable model were weighted based on the outcome (HIV testing) using 
weights unique to the data collection years.
 Results
In Cycle 1, 750 heterosexuals at elevated risk for HIV were recruited; in Cycle 2, 482 were 
recruited. Demographic and sexual behavior characteristics are presented in Table 1. The 
majority of study participants were black and more than half were female. There were no 
differences in age, education, employment status, income, and health insurance status 
between the two groups. A higher proportion of participants from Cycle 1 self-identified as 
being heterosexual than from Cycle 2 (90% versus 81%, respectively; chi-square: 7.16, 
p=0.03), higher proportions of former and current homelessness were observed in the Cycle 
2 sample versus in the Cycle 1 sample (chi-square: 28.7, p<0.0001) as well as being arrested 
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in the past 12 months (chi-square: 4.48, p=0.03). In addition, a larger proportion of 
participants in the Cycle 2 sample had four or more partners and engaged in anal sex, and a 
smaller proportion engaged in vaginal sex compared to participants recruited in Cycle 1. 
Condom use at last vaginal and anal sex did not differ across the two groups.
HIV seroprevalence was elevated compared to the estimated general prevalence in 
Washington, DC across both groups (Table 2), but did not differ statistically across study 
cycles (5.2% and 8.0% in Cycles 1 and 2, respectively; chi-square: 1.17, p=0.28). In 
addition, although the overall HIV prevalence in Cycle 2 was higher, the proportion of newly 
identified positives was lower in Cycle 2 versus Cycle 1 (21% versus 48%; chi-square: 1.74, 
p=0.19), although this was also not statistically significantly different. The majority had ever 
tested for HIV (88% and 85% in Cycles 1 and 2, respectively; chi-square: 0.02, p=0.88); 
among those, individuals enrolled in Cycle 2 versus Cycle 1 were significantly more likely 
to have been tested in the past two years (83% vs. 76%; chi-square: 4.81, p=0.03). There was 
no significant difference in the proportion of participants who reported testing in the past 
year. Participants from Cycle 2 were more likely to report being tested with an oral swab 
than those recruited during Cycle 1 (61% versus 41%, respectively; chi-square: 24.5, 
p<0.0001). There were no differences in being offered the HIV test at last health care visit 
between data collection years.
In the multivariable analyses identifying correlates of past year testing (Table 3), having seen 
a health care provider in the past 12 months (adjusted odds ratio [aOR]: 3.7, 95% confidence 
interval [CI]: 2.3, 5.9) and using condoms at last vaginal sex (aOR: 1.7, 95% CI: 1.1, 2.5) 
were independently associated with testing for HIV in the past year after adjusting for study 
cycle. Study cycle was not significantly associated with testing for HIV in the past 12 
months.
 Discussion
In this study of heterosexuals at elevated risk for HIV in Washington, DC, the proportion of 
individuals who reported HIV testing in the past two years was higher in Cycle 2 versus 
Cycle 1, yet no differences existed in the proportion of individuals who tested in the past 
year. However, having seen a medical provider in the past 12 months was independently 
associated with having been tested in the past year. This may be explained by the onset of 
the DC HIV testing campaign, which focused part of its campaign on implementing routine 
testing at all medical encounters for all citizens between the ages of 13-84 years (9). Other 
jurisdictions have launched city-wide routine testing programs, such as the Bronx, New York 
(22) and the Washington, DC Veterans Administration system (23) and have observed 
increased prevalence of both lifetime and past-year testing based on post-campaign 
evaluations.
It is important to note that lifetime HIV testing in Washington, DC has been observed to be 
consistently high, ranging from 75% according to data from the Behavioral Risk Factors 
Surveillance System (BRFSS) in 2008 (24) to 68% among those who tested as part of the 
DC routine HIV testing campaign (9) to 85-88% in these data. The proportions we observed 
in the NHBS samples were higher, which may be due to specific sampling from a high-risk 
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heterosexual population versus the U.S. general population as in the BRFSS or the DC 
general population.
For the DC testing campaign, major efforts were focused on expanding capacity for testing 
at community-based organizations and medical facilities, greater access to rapid HIV test 
kits at no cost, and direct marketing about the importance of HIV screening to DC residents 
(9, 10, 25), with the ultimate goal of “laying the foundation for an expanding HIV testing 
program by 2008” (25). Specific efforts to expand HIV testing in medical facilities included 
testing in emergency rooms (12), in-patient hospital settings (11), and primary care 
physician offices (9). Approximately two-thirds of individuals tested as part of the DC HIV 
screening campaign in 2006 reported having ever been tested before, and of those, less than 
half had been tested in the past 12 months (9), which is lower than the proportions we 
observed in the NHBS-recruited samples (56%-61%). Regardless, the proportion of 
individuals testing in the past year did not differ between the two groups, confirming that the 
recommendation for annual testing has not yet been fully adopted across the city, 
particularly among this population at risk. However, self-reported testing within the past two 
years was significantly higher in the Cycle 2 sample, suggesting that, while individuals are 
not testing as frequently as recommended by the CDC, the expanded testing campaign has 
been effective in increasing the proportion of recent testers compared to individuals who 
were recruited during the time the campaign was commencing. The significant change in the 
proportion of individuals testing using an oral rapid test, which was the kind of test that was 
distributed by the DC DOH at no cost to community-based organizations and medical 
facilities for the HIV testing initiative, suggests that the expansion of testing as observed in 
the increase of past two year testing was likely a result of the DOH HIV testing initiative. In 
addition, although not statistically significant, a lower proportion of newly positive 
individuals was identified in Cycle 2 compared to Cycle 1, also suggesting that despite 
reporting a higher prevalence of risk behaviors, the Cycle 2 sample may be more likely to 
know their status as a result of the expanded testing program that occurred in previous years. 
This is consistent with DC HIV surveillance data which demonstrated an increase in new 
HIV diagnoses between 2005 and 2007, yet decreased number of new diagnoses after that 
(1).
Although the proportion of individuals testing in the past year did not differ across the two 
time points, we observed an independent association between seeing a healthcare provider in 
the past year and being tested in the past year, regardless of study year. This suggests and 
underscores that healthcare providers are an important component of expanding HIV testing 
among high risk heterosexual populations. The proportion of individuals who were offered 
HIV testing at their last visit with a health care provider was slightly higher in Cycle 2 but 
was not statistically significantly different from the Cycle 1 time period. Despite a major 
initiative to educate and promote routine HIV testing among medical professionals in DC 
which was launched in 2007 (25), only half of participants were offered HIV testing through 
their medical provider, a proportion that should be increased in order to maximize the impact 
of HIV testing expansion in Washington, DC. Because it is believed that one-fifth of HIV-
positive individuals are undiagnosed, the offer of routine testing at all medical encounters is 
critical for a city like Washington, DC with a high HIV prevalence.
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There are both limitations and strengths to this analysis. First, although HIV serostatus is 
measured by serologic testing, the behavioral and testing data collected for NHBS are by 
self-report; therefore, the exact dates of testing may not be fully valid and are subject to 
recall. However, study interviewers were highly trained to objectively probe study 
participants for the most accurate date possible. Second, the timing of launch of the DC 
testing initiative overlapped with data collection for Cycle 1; therefore, the high proportion 
of lifetime and past year testing in Cycle 1 may reflect the beginning of the expanded HIV 
testing initiative. To estimate the potential effect the emerging testing campaign may have 
had on HIV testing in Cycle 1, HET-1 study participants were asked whether they had heard 
about the DC HIV screening campaign; only 31% had heard of the program (unpublished 
data). Lastly, the eligibility and recruitment criteria differed slightly between the two data 
collection years; therefore, the data presented are suggestive of trends and direct 
comparisons should not be made. Regardless, these data give researchers and public health 
pracitioners a snapshot of current testing behaviors beyond clinic and CBO settings. A major 
strength of this analysis is the use of community-based samples of heterosexuals at elevated 
risk for HIV that were assembled using rigorous, CDC-developed protocols. The use of RDS 
allows for a sample that may be generalizable to the networks from which these samples 
were drawn. Because there is no known sampling frame for heterosexuals at elevated risk for 
HIV, RDS is thought to be superior to convenience and snowball sampling (17, 19, 26). An 
additional strength is the ability to compare testing behaviors between these two time points, 
during which the expanded HIV testing initiative was launched. Although the eligibility and 
recruitment criteria were slightly different, the majority of the samples were recruited from 
the same neighborhoods and census tracts (data not shown).
In conclusion, past year HIV testing rates in Washington, DC among heterosexuals at 
elevated risk for HIV were relatively similar between Cycle 1 and Cycle 2, yet the 
proportion testing in the past two years was higher in Cycle 2, likely due to the District’s 
city-wide expanded testing program introduced during Cycle 1. Due to the high HIV 
prevalence in DC, annual routine testing, as recommended by the CDC, should be further 
reinforced above and beyond the HIV testing campaigns. One of the reasons for the lack of 
change in past year testing could signal a “plateauing” of the reach of the HIV testing 
initiative, suggesting that additional methods of reaching populations at risk for HIV, 
including heterosexuals, should be explored to increase HIV test-seeking behaviors. 
Continued surveillance of adherence to HIV testing recommendations and identification of 
individual level and structural barriers to annual testing among both consumers and health 
care providers is critical in order to increase knowledge of one’s status and to reduce the 
proportion of undiagnosed HIV cases in the city and interrupt transmission. Although past 
year testing was associated with seeing a health care provider, simultaneous efforts should 
be made to increase coverage of routine HIV testing at all health care visits, particularly with 
this at-risk group. Given that HIV testing is one of the cornerstones of HIV prevention, 
interventions to increase testing among those at risk for HIV are critical in meeting national 
HIV/AIDS strategy goals.
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Table 1
Demographic and behavioral characteristics of NHBS Cycle 1 (2006-7) and Cycle 2 (2010) samples of 
heterosexuals at elevated risk for HIV from NHBS, Washington, DC.
Cycle 1 (2006-7) n=750 Weighted % Cycle 2 (2010) n=482 Weighted % X2 p-value*
Female 60.7 54.0 1.81 0.18
Black 93.8 89.0 1.93 0.16
<30 years old 39.2 40.6 0.09 0.76
Sexual preference: heterosexual 89.5 80.9 7.16 0.03
Less than high school graduate 37.6 35.8 0.38 0.54
Employed (full-time or part-time) 29.0 30.3 0.33 0.57
<$10,000 annual income 60.0 61.8 2.81 0.42
Have current health insurance 81.3 78.9 0.05 0.83
Housing
 Formerly homeless 7.9 21.6 28.7 <0.0001
 Currently homeless 13.9 22.9
 Never homeless 78.1 55.5
Arrested past 12 mo 18.6 25.4 4.48 0.03
# Sex partners past 12 mo**
 1 42.1 37.1 6.74 0.03
 2 – 3 35.5 29.9
 4+ 22.4 33.0
Type of partner at last sex past 12 mo
 Main 72.9 62.4 6.39 0.04
 Casual 20.6 30.2
 Exchange 6.4 7.4
Had vaginal sex past 12 mo 98.5 90.4 16.7 <0.0001
  If yes: used condom 28.8 25.5 0.27 0.60
Had anal sex past 12 mo 7.6 17.7 13.7 0.0002
  If yes: used condom 9.2 21.6 2.91 0.09
*
Chi-square test across HET-1 and HET-2.
**
Includes opposite and same sex partners.
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Table 2
HIV prevalence and testing behaviors among NHBS Cycle 1 (2006-7) and Cycle 2 (2010) samples of 
heterosexuals at elevated risk for HIV, Washington, DC.
Cycle 1 (2006-7) n=750 
Weighted %
Cycle 2 (2010) n=482 Weighted 
% X2 p-value
HIV Prevalence 5.2 8.0 1.17 0.28
 If positive, new HIV positive 47.4 20.6 1.74 0.19
Ever HIV tested previously 87.9 84.7 0.02 0.88
 If yes: test within past 24 mo. 76.0 83.0 4.81 0.03
 If yes: test within past 12 mo. 60.9 55.8 0.60 0.44
Specimen Type of Last Test
 Swab from mouth 41.1 60.5 24.5 <0.0001
 Blood from arm 52.3 30.9
 Blood from finger 6.5 8.0
Facility Type at which Last Test Taken
 Community health center / public health clinic 26.5 32.6 10.3 0.41
 HIV/AIDS street outreach / mobile unit 13.7 15.6
 Correctional facility 10.7 9.1
 Private doctor’s office 9.9 10.9
 HIV counseling & testing site 7.4 7.5
 Hospital (inpatient) 5.4 6.0
 Prenatal/Obstetrics/Family planning clinic 4.6 1.7
 STD/HIV/AIDS clinic 3.9 2.8
 Drug treatment program 3.9 2.6
 Emergency room 3.1 5.1
 Other* 10.8 6.2
Confidentiality of Test
 Anonymous 32.5 39.2 1.56 0.21
 Confidential 65.6 60.8
 Don’t know 1.9 --**
Saw health care provider, past 12 mo 79.7 72.4 2.49 0.11
 If yes, offered an HIV test 50.6 56.3 3.03 0.08
*
Other options included: military, at home, and other
**
”Don’t know” was not an option in 2010.
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Table 3
Weighted multivariable logistic regression model of correlates of testing for HIV in the past 12 months among 
heterosexuals at elevated risk for HIV from NHBS Cycle 1 (2006-7) and Cycle 2 (2010) samples, Washington, 
DC.
Adjusted* Odds Ratio 95% Confidence Interval p-value
Data collection cycle
 Cycle 1 (2006-7) 1.0 ref
 Cycle 2 (2010) 0.96 0.65, 1.42 0.84
Saw health care provider, past 12 mo
 No 1.0 ref
 Yes 3.68 2.29, 5.89 <0.0001
Used condom at last vaginal sex
 No 1.0 ref
 Yes 1.65 1.07, 2.54 0.02
*
Adjusted for variables listed in table.
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